CIK 0001858685 · <br>Emerging growth company
Biofrontera Inc.
Sign in to watch- Tickers
- BFRI BFRIW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473765675
- Phone
- 781-245-1325
- Business address
- 120 PRESIDENTIAL WAY,, SUITE 330, WOBURN, MA, 01801
Securities
- BFRI Common Stock Nasdaq
- BFRIW Common stock Nasdaq
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Delisting notice
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- 8-K Event Auditor change
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Results of operations
- 10-K Report Annual Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · New debt or obligation · Delisting notice
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 5 of 19 · 365 filings